A treaty too many
India is learning that there is a heavy price to be paid for the large number of bilateral investment treaties, or BITs, it has signed in the …
Fading history of Novartis v Union of India
The 2013 landmark Supreme Court judgement offers critical lessons on the intent behind crucial aspects of India’s key patent law
Bedaquiline patent win is a half victory
India’s ability to eliminate its huge TB burden by 2025 will be a test of both its patent laws and healthcare policy
Outsourcing patent functions
WIPO begins talks on controversial proposal to allow countries to outsource their patent examination processes to another country
Competitive policies
The Ericsson case highlights the uneasy interface between competition policy and patent law
Cyborg controversy
There's gaiety on the greens as the European Parliament drops a directive on patenting genetically-engineered life-forms
Civil society challenges patents on Hepatitis C drugs
Pharmaceutical corporations obtain unjustified patents making the drugs unaffordable to many, petitioners claim
Mother Teresa's blue and white sari has been trademarked to avoid misuse. But to what end?
The blue and white sari was registered as the Inteleectual Property of the Missionaries of Charity in September 2016 immediately after Mother …
When judges copy
Should the rules on plagiarism matter as much as the independent analysis made by judges in adjudicating cases?
Patanjali doesn't want to share benefits of centuries-old medicine system
Ramdev's corporate behemoth Patanjali's claim that Indian firms do not have to share benefits for using bio resources is troubling
Revoking Monsanto's GM cotton patent is of little help to farmers let down by the technology
Designed to resist the bollworm pest, Monsanto's Bollgard II is seen as useless as the pink bollworm ravages cotton fields across the country
India’s 3 D Message
The Supreme Court judgment in the Novartis case clearly upholds India’s patent laws, not weakens the patent regime
AI throws patent system into turmoil — especially in drug discovery
Artificial intelligence is overturning the conventional idea of intellectual property rights
Moderna’s brazen patent grab on a COVID-19 jab
The US administration is finally putting its foot down on the appropriation of public research by drug firms
The madness of software patents
India’s patent law excludes software per se, yet over a thousand patents have been granted
Obama takes first dip
The US becomes the first to join a global patents pool to make AIDS drugs cheaper but health workers are sceptical of the initiative
Can activism check Big Pharma’s profit motives?
As prices of life-saving drugs skyrocket, people from diverse fields are getting together to fight Big Pharma
Clearing the smoke on packaging
WTO rules that Australian laws on tobacco packaging don't violate global obligations to protect intellectual property
Pressed for sharing
The Uttarakhand high court order on Ramdev's firm to pay for use of bioresources has put herbal companies on notice
Dummy’s guide to how trade rules affect access to COVID-19 vaccines
The WTO is considering whether to temporarily waive certain rules about TRIPS, to allow more countries access to vaccines, drugs needed to …
Trial after error
The Supreme Court's decision to resend Monsanto's Bt cotton case to the trial court will ensure judicial scrutiny of all aspects of the patent …
Obama visit: civil society appeals to Modi not to succumb to US pressure on IP laws
US actions jeopardise India’s pro-poor patent laws that promote generic drugs production, says online global petition
India opposes patent application by British company
Earlier, an attempt by Colgate-Palmolive to use patent on a mouthwash was also foiled
Books for visually impaired to be widely available
New international agreement, being described as 'miracle' treaty, needs to be ratified by 20 countries for it to come into effect
New ruse in Big Pharma's old game
Drug multinationals are lobbying for a devious patent linkage system to block the entry of competitive generics